Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Noradrenergic and adrenergic functioning in autism

R B Minderaa1, G M Anderson, F R Volkmar

  • 1Department of Child Psychiatry, University of Groningen, The Netherlands.

Biological Psychiatry
|August 15, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of the serotonin transporter gene in the behavioral expression of autism.

Molecular psychiatry·2001
Same author

Mothers' functioning and children's symptoms 5 years after a SCUD missile attack.

The American journal of psychiatry·2001
Same author

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.

The American journal of psychiatry·2001
Same author

3-Carboxamido analogues of morphine and naltrexone. synthesis and opioid receptor binding properties.

Bioorganic & medicinal chemistry letters·2001
Same author

Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

The New England journal of medicine·2001
Same author

Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy.

The American journal of cardiology·2001

This study found no significant differences in noradrenergic functioning between autistic individuals and controls. Autistic individuals do not appear to have basal noradrenergic abnormalities.

Area of Science:

  • Neuroscience
  • Biochemistry

Background:

  • Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition.
  • Noradrenergic and adrenergic systems play crucial roles in brain function and behavior.

Purpose of the Study:

  • To investigate neurochemical differences in noradrenergic and adrenergic functioning between individuals with autism and neurotypical controls.
  • To assess basal levels of key neurotransmitters and their metabolites in plasma and urine.

Main Methods:

  • Measured plasma levels and urinary excretion of 3-methoxy-4-hydroxy-phenylglycol (MHPG).
  • Quantified urinary excretion rates of norepinephrine (NE), epinephrine (EPI), and vanillylmandelic acid (VMA).
  • Compared neurochemical data between autistic patients (unmedicated and medicated) and normal controls.

Related Experiment Videos

Main Results:

  • No significant group mean differences were observed in MHPG, NE, EPI, or VMA levels between autistic and control groups.
  • Both groups exhibited higher urinary excretion rates of NE and EPI during the afternoon-evening compared to overnight periods.
  • These findings suggest no marked abnormalities in basal noradrenergic functioning in autism.

Conclusions:

  • Basal noradrenergic functioning does not appear to be significantly impaired in individuals with autism.
  • Further research may explore other neurochemical systems or specific subgroups within the autism spectrum.